2 results
Approved WMOCompleted
Efficacy and safety trial with S 44819 after recent ischemic cerebral Event
Approved WMOWill not start
The primary objective of this study is to determine if ambrisentan is effective in delaying disease progression and death in subjects with IPF.Secondary objectives include evaluation of the safety and effect of ambrisentan on development of…